MGLL and cholestasis: Notably, pharmacological (JZL184) inhibition of MGL also ameliorated DDC‐induced cholestasis and protected Mdr2−/− mice from spontaneous liver injury improving liver enzymes, inflammation, and biliary fibrosis.